Sign in
4

Changes in Ownership

Inhibitor Therapeutics, Inc. Filed Acc 0001560183-16-000003

10% owner acquired 27,885,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mayne Pharma Group Ltd 10% owner 2016-05-25 Grant or award +27,885,000 149,062,230 I
Derivatives
Mayne Pharma Group Ltd 10% owner 2016-05-25 Grant or award · Warrant to Purchase Common Stock +28,364,236 71,948,138 I
Loading xslF345X03/primary_doc.xml…